PFWA
ICPT

Paces Ferry Wealth Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Paces Ferry Wealth Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7
Closed – – 1194
2020
Q3 		$0 Buy
+7
New +$322 ﹤0.01% 1278

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Paces Ferry Wealth Advisors's ICPT Position: Q4 2020 in Review

Paces Ferry Wealth Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2020, closing a stake of 7 shares.

Paces Ferry Wealth Advisors first reported a position in ICPT in Q3 2020 and held it in 1 quarter. The position peaked at $0 in Q3 2020. 175 funds tracked by Wall St. Rank hold ICPT as of Q4 2020.

  • Paces Ferry Wealth Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Paces Ferry Wealth Advisors sold 7 Intercept Pharmaceuticals, Inc. shares in Q4 2020.
  • Paces Ferry Wealth Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Paces Ferry Wealth Advisors's Intercept Pharmaceuticals, Inc. position peaked at $0 in Q3 2020.
  • 175 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2020.

Based on Paces Ferry Wealth Advisors's 13F filing for Q4 2020, filed 5 Mar 2021.